Biogen Inc. buy Needham & Company LLC
Start price
11.04.23
/
50%
€257.80
Target price
11.04.24
€297.70
Performance (%)
-26.01%
End price
12.04.24
€190.75
Summary
This prediction ended on 12.04.24 with a price of €190.75. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.01%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 3.296% | 3.296% | 50.228% | -44.003% |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% | 50.231% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% | 101.082% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% | 69.384% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% | 70.971% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $325.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten